Sg3 Management, LLC United Therapeutics Corp Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $559,392 - $771,648	-3,200 Reduced 16.0%	16,800 $3.96 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $3.32 Million - $4.28 Million	20,000 New	20,000 $3.59 Million
Q4 2021 Feb 15, 2022	SELL	$184.32 - $216.08 $1.84 Million - $2.16 Million	-10,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $1.8 Million - $2.15 Million	10,000 New	10,000 $1.85 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $2.56 Million - $3.18 Million	-15,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $1.53 Million - $2.28 Million	15,000 New	15,000 $2.28 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.